Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wils

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal GroupJ Wils, G H Blijham, Th Wagener, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 25, 2023
The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakiaLeon J Wils, Jos B Poell, Laura A N Peferoen, et al.
World Journal of Urology|June 24, 2003
A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of lifeG van Andel, P Fernandez de Moral, C T M Caris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patientsC H Köhne, D Cunningham, F Di Costanzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trialC Grimaldi, H Bleiberg, F Gay, et al.
Lancet (London, England)|September 12, 1998
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer ResearchP Rougier, T Sahmoud, D Nitti, et al.
Oral Diseases|November 8, 2023
The value of regular follow-up of oral leukoplakia for early detection of malignant transformationIlkay Evren, Ahmad M Najim, Jos B Poell, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)E Van Cutsem, M Dicato, J Wils, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative GroupT Conroy, P L Etienne, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survivalT Conroy, P L Etienne, A Adenis, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal GroupJ Wils, G H Blijham, Th Wagener, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|September 25, 2023
The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakiaLeon J Wils, Jos B Poell, Laura A N Peferoen, et al.
World Journal of Urology|June 24, 2003
A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of lifeG van Andel, P Fernandez de Moral, C T M Caris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patientsC H Köhne, D Cunningham, F Di Costanzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trialC Grimaldi, H Bleiberg, F Gay, et al.
Lancet (London, England)|September 12, 1998
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer ResearchP Rougier, T Sahmoud, D Nitti, et al.
Oral Diseases|November 8, 2023
The value of regular follow-up of oral leukoplakia for early detection of malignant transformationIlkay Evren, Ahmad M Najim, Jos B Poell, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)E Van Cutsem, M Dicato, J Wils, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative GroupT Conroy, P L Etienne, A Adenis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survivalT Conroy, P L Etienne, A Adenis, et al.
Pageof 12